Private Equity Detox—Bain Capital Sheds Emcure Shares Worth ₹574 Crores

Unknown Apr 02, 2026 1,050 Views

In a substantial secondary market transaction, BC Investments IV Ltd, a subsidiary of Bain Capital, sold 4.5 million shares of Emcure Pharmaceuticals Ltd. in a block deal on the National Stock Exchange. The transaction, for a 2.4% stake, was executed at an average price of ₹1,262 per share for a...